Grifols stock edges into focus on $6.884 billion market cap
Published on 08/17/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Grifols stock (ES0171996087) is backed by a $6.884 billion market cap and a $0.26 EPS (TTM), while the shares also traded in a $8.52 to $8.66 range in the latest quote snapshot.
Market context
The latest Yahoo Finance snapshot shows a previous close of $8.66, a day range of $8.52 to $8.66, and a 52-week band of $5.30 to $12.15. The same snapshot lists average volume at 1,443,362 shares, giving the stock a clear liquidity reference as of August 16, 2026.
Latest reported figures
Grifols is also entering a week that one market calendar page flags as relevant, with the name listed for Monday coverage. The most concrete operating figure in the available snapshot set is the $0.26 EPS (TTM), which sits beside a market cap that remains below the 52-week high by $3.49 a share.
Product view
Grifols develops plasma-derived medicines and transfusion medicine products across more than 110 countries and regions, according to its company profile language surfaced in the live results.
Price and setup
The quote snapshot places Grifols at $8.66 on August 16, 2026, with the stock still trading well above the $5.30 low in the 52-week range. That leaves the shares $3.49 below the $12.15 high, a gap that matters for traders watching the next move.
Fact box
Company: Grifols, S.A.
ISIN: ES0171996087
Ticker: GRFS
Exchange: Nasdaq
Price (as of August 16, 2026): $8.66 USD
Market cap: $6.884 billion
Sector / Industry: Health Care / Biotechnology
Index membership: Not verified in the live results
More on Grifols stock
Investor Relations
